MetLife, Inc. (MET) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "MET",
        "METpA",
        "METpE",
        "METpF"
      ],
      "issuer_cik": "0001099219",
      "owner_cik": "0001770295",
      "accession_number": "0001770295-26-000007",
      "form_type": "4",
      "filing_date": "2026-06-03",
      "period_of_report": "2026-06-01",
      "issuer_name": "METLIFE INC",
      "issuer_trading_symbol": "MET",
      "owner_name": "DEBEL MARLENE",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "EVP & Chief Risk Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-06-01",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 21312,
      "transaction_price_per_share": 81.5889,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 154380,
      "transaction_value": 1738822.6368,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price."
        }
      ]
    }
  ]
}

// trimmed to 1 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.